• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

N Engl J Med. Stalking Influenza Diversity with a Universal Antibody

Giuseppe

Emeritus
[Source: The New England Journal of Medicine, full text: (LINK). Extract, edited.]

Clinical Implications of Basic Research
Stalking Influenza Diversity with a Universal Antibody



Charles J. Russell, Ph.D.

N Engl J Med 2011; 365:1541-1542 October 20, 2011

This article has no abstract; the first 100 words appear below.


The back-and-forth battle between influenza viruses and humans is defined by diversity. We fight previously unseen pathogens with a diverse repertoire of antibodies, and influenza viruses evade our immune system by presenting us with diverse surface-protein sequences. Corti and colleagues have recently discovered a universal influenza antibody, revealing an Achilles' heel common to all influenza strains that we can now target with next-generation antiviral drugs and vaccines.
The current co
untermeasures against seasonal influenza are the use of annual vaccines and antiviral drugs, such as oseltamivir. Seasonal strains (presently, H1N1, H3N2, and B type) evade our immune systems after vaccination or (?)

Disclosure forms provided by the author are available with the full text of this article at NEJM.org.
- ------
 
Back
Top Bottom